No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
TMO240719P540000
- 3.50
- +1.76+101.15%
15min DelayClose Jul 18 16:00 ET
6.42High1.50Low
1.50Open1.74Pre Close119 Volume268 Open Interest540.00Strike Price47.50KTurnover36.52%IV0.76%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry3.50Extrinsic Value100Contract SizeAmericanOptions Type-0.4679Delta0.0420Gamma156.70Leverage Ratio-2.2628Theta-0.0056Rho-73.32Eff Leverage0.1033Vega
Intraday
- 5D
- Daily
News
$7.1 Billion Medical Refrigerators Market and Industry Insights, 2024-2030, Featuring Strategic Analysis of 42 Major Players, Including Godrej, Haier Biomedical, Thermo Fisher Scientific
Thermo Fisher Scientific's (NYSE:TMO) 14% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period
CytoReason Secures $80M From OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts
New funding will expand CytoReason's disease models and proprietary data, enabling R&D leaders at partner companies to make strategic decisions with greater speed and precision.TEL AVIV, Israel--(
NIH Outlays Rise by 5% in June, Says Baird
AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates
The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific
Comments
Morning Movers
Gapping up
$Tesla(TSLA.US$ stock soared 12% following the announcement of earlier releases for "more affordable" car versions, despite first-quarter results falling short of Wall Street estimates.
$AT&T(T.US$ stock increased by 3.6% after reporting stronger-than-expected subscriber growth and surpassing free cash flow growth in the first quarter.
$Visa(V.US$ stock grew 2.4% as the credit card company's second...
Gapping up
$Tesla(TSLA.US$ stock soared 12% following the announcement of earlier releases for "more affordable" car versions, despite first-quarter results falling short of Wall Street estimates.
$AT&T(T.US$ stock increased by 3.6% after reporting stronger-than-expected subscriber growth and surpassing free cash flow growth in the first quarter.
$Visa(V.US$ stock grew 2.4% as the credit card company's second...
24
1
Nvidia $NVIDIA(NVDA.US$
Walmart $Walmart(WMT.US$
$Advanced Micro Devices(AMD.US$
Costco $Costco(COST.US$
Taiwan Semiconductor $Taiwan Semiconductor(TSM.US$
CrowdStrike $CrowdStrike(CRWD.US$
JPMorgan $JPMorgan(JPM.US$
Airbnb $Airbnb(ABNB.US$
Palantir $Palantir(PLTR.US$
Qualcomm $Qualcomm(QCOM.US$
Target $Target(TGT.US$
Bank of America $Bank of America(BAC.US$
Wells Fargo $Wells Fargo & Co(WFC.US$
Spotify $Spotify Technology(SPOT.US$
...
Walmart $Walmart(WMT.US$
$Advanced Micro Devices(AMD.US$
Costco $Costco(COST.US$
Taiwan Semiconductor $Taiwan Semiconductor(TSM.US$
CrowdStrike $CrowdStrike(CRWD.US$
JPMorgan $JPMorgan(JPM.US$
Airbnb $Airbnb(ABNB.US$
Palantir $Palantir(PLTR.US$
Qualcomm $Qualcomm(QCOM.US$
Target $Target(TGT.US$
Bank of America $Bank of America(BAC.US$
Wells Fargo $Wells Fargo & Co(WFC.US$
Spotify $Spotify Technology(SPOT.US$
...
13
3
The share price has tracked EPS growth, suggesting unchanged sentiment towards the shares. The recent sell-off could be an opportunity, given the long-term gain of 18% per year over half a decade. However, investors should note 1 warning sign for Thermo Fisher Scientific before investing.
Morning Movers
Gapping up
$Starbucks(SBUX.US$ stock rose 3.7% after the coffee chain cut its annual sales forecast, warning of softer demand in January and a slow recovery in China. However, even more weakness had been expected following disappointing store traffic in November and December.
$Novo-Nordisk A/S(NVO.US$ stock rose 0.5% after the Danish drugmaker forecast another year of double-digit growth due to the populari...
Gapping up
$Starbucks(SBUX.US$ stock rose 3.7% after the coffee chain cut its annual sales forecast, warning of softer demand in January and a slow recovery in China. However, even more weakness had been expected following disappointing store traffic in November and December.
$Novo-Nordisk A/S(NVO.US$ stock rose 0.5% after the Danish drugmaker forecast another year of double-digit growth due to the populari...
17
Read more
silversurfer222 : ahhhh credit cards... the beast system of church and state ... the fools flock to be saved from the hell they are already in
...
don't ask the Christians to save you they do nothing while waiting for a second coming that isn't coming...
christ consciousness buffoons